Moderna files for European authorization of updated COVID vaccine
July 3 (Reuters) - U.S. biotech firm Moderna (MRNA.O) said on Monday it had submitted a regulatory application to the European Medicines Agency (EMA) seeking authorization for its updated COVID-19 vaccine to target the XBB.1.5 sub-variant.
Reporting by Eva Mathews in Bengaluru; Editing by Rashmi Aich
Our Standards: The Thomson Reuters Trust Principles.
